| 1 |
2024 |
Robert Roskoski Jr., Targeted and cytotoxic inhibitors used in the treatment of lung cancers, Pharmacological Research. 2024; 209: 107465107465.
https://doi.org/10.1016/j.phrs.2024.107465 |
| 2 |
2025 |
Yuzhu Chen, Fei Qi, Chenhao Sun, Peng Jiang, Xiangyu Xue, Xiaomei Yang, Xiaomi Li, Xin He, Yishuo Wang, Tongmei Zhang. Navigating the landscape of neoadjuvant immunotherapy for NSCLC: progress and controversies, Therapeutic Advances in Medical Oncology. 2025; 17: 17588359241312501.
https://doi.org/10.1177/17588359241312501 |
| 3 |
2025 |
Giorgio Facheris, Gianluca Cossali, Jessica Imbrescia, Salvatore La Mattina, Eneida Mataj, Nicole Meli, Giulia Volpi, Luca Triggiani, Andrea Emanuele Guerini, Guido Levi, Salvatore Grisanti, Michela Buglione di Monale e Bastia, Paolo Borghetti. Real-World Insights into the Impact of Durvalumab on Stage III Unresectable Non-Small Cell Lung Cancer—A Narrative Review, Cancers. 2025; 17: 874.
https://doi.org/10.3390/cancers17050874 |
